Live Breaking News & Updates on Assessment Aid

Stay updated with breaking news from Assessment aid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA approves erdafitinib for locally advanced or metastatic urothelial carcinoma (JNJ)

FDA approves erdafitinib for locally advanced or metastatic urothelial carcinoma (JNJ)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Drug Administration , Janssen Biotech , Assessment Aid , Expedited Programs , Serious Conditions Drugs , Watch Reporting System ,

FDA Approves Capivasertib With Fulvestrant for PIK3CA/ALT1/PTEN Alterations Breast Cancer

Capivasertib is indicated for hormone receptor-positive, human epidermal growth factor 2-negative locally advanced or metastatic breast cancer with 1 or more PIK3CA/ALT1/PTEN-alterations. ....

Astrazeneca Pharmaceuticals , Breast Cancer Research , Locally Advanced , For Papers , Pharmacy Times Oncology , Assessment Aid ,

BeiGene's (BGNE) zanubrutinib approved by FDA for lymphocytic leukemia

BeiGene's (BGNE) zanubrutinib approved by FDA for lymphocytic leukemia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Beigene United States Inc , Drug Administration , Beigene United States , Assessment Aid ,

FDA's RTOR Program Draft Guidance Insights

First launched in Feb. 2018 by the FDA’s Oncology Center of Excellence, the Real-Time Oncology Review (RTOR) program is intended to streamline. ....

United States , Marjoriee Zettler , Jazz Pharmaceuticals Inc , Oncology Center , Novartis Pharmaceuticals Corporation , Drug Administration , Regor Pharmaceuticals Inc , Seattle Genetics Inc , Time Oncology Review Program , Regor Pharmaceuticals , Real Time Oncology Review , Rolling Review , Prescription Drug User Fee Act , Assessment Aid , Hematologic Malignancies Approval Notifications , New Drug Application , Biologics License Application , Jazz Pharmaceuticals , States Food , Hematologic Malignancies Approval , Initial Experience , Clin Cancer ,

FDA's RTOR Program Draft Guidance Insights

First launched in Feb. 2018 by the FDA’s Oncology Center of Excellence, the Real-Time Oncology Review (RTOR) program is intended to streamline. ....

United States , Marjoriee Zettler , Jazz Pharmaceuticals Inc , Oncology Center , Novartis Pharmaceuticals Corporation , Drug Administration , Regor Pharmaceuticals Inc , Seattle Genetics Inc , Time Oncology Review Program , Regor Pharmaceuticals , Real Time Oncology Review , Rolling Review , Prescription Drug User Fee Act , Assessment Aid , Hematologic Malignancies Approval Notifications , New Drug Application , Biologics License Application , Jazz Pharmaceuticals , States Food , Hematologic Malignancies Approval , Initial Experience , Clin Cancer ,